0001062993-20-004556.txt : 20200917 0001062993-20-004556.hdr.sgml : 20200917 20200917170704 ACCESSION NUMBER: 0001062993-20-004556 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200915 FILED AS OF DATE: 20200917 DATE AS OF CHANGE: 20200917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VERU DENNISON T CENTRAL INDEX KEY: 0001225341 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 201181804 MAIL ADDRESS: STREET 1: C/O PALIDADE CAPITAL STREET 2: ONE BRIDGE PLAZA NORTH #695 CITY: FORT LEE STATE: NJ ZIP: 07024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Brickell Biotech, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2020-09-15 0000819050 Brickell Biotech, Inc. BBI 0001225341 VERU DENNISON T C/O BRICKELL BIOTECH, INC. 5777 CENTRAL AVENUE, SUITE 102 BOULDER CO 80301 1 0 0 0 Common Stock 2020-09-14 5 G 0 E 19642 0 D 7230 D Common Stock 2020-09-15 4 A 0 13580 .81 A 20810 D Common Stock 2020-09-15 4 P 0 15355 .8086 A 36165 D Common Stock 2020-09-16 4 P 0 14645 .8029 A 50810 D Common Stock 2020-09-14 5 G 0 E 19642 0 A 980030 I By self due to Control over the Entity that holds Shares Stock Option (right to buy) .80 2020-09-15 4 A 0 60000 0 A 2030-09-15 Common Stock 60000 60000 D On September 15, 2020, the reporting person was granted 13,580 restricted stock units ("RSUs") in lieu of a portion of cash compensation as a director of Brickell Biotech, Inc. The RSUs are scheduled to vest on December 31, 2020 and will be settled in the form of one share of common stock for each RSU. Represents the purchase of 15,355 shares in multiple transactions, ranging in price from $0.80 to $0.8153 per share, resulting in a weighted average purchase price of $0.8086. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range. Represents the purchase of 14,645 shares in multiple transactions, ranging in price from $0.80 to $0.81 per share, resulting in a weighted average purchase price of $0.8029. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range. The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years. /s/ Christine G. Long, Attorney-in-Fact for Dennison T. Veru (power of attorney previously filed) 2020-09-17